Parkinson's Disease Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People diagnosed with Parkinson's disease who have deep brain stimulation (DBS) devices placed on both sides of the brain in a specific brain region called the subthalamic nucleus (STN).
- People who had their current DBS system (the Percept™ PC or RC device) implanted at least 6 months ago.
- People who still experience symptoms such as difficulty speaking, episodes of freezing (sudden inability to move), or unpredictable "on-off" periods where their medication stops working well enough.
- People whose DBS device is producing a usable brain signal (called an LFP signal) on at least one side of the brain.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People whose treating doctor considers it clinically unsafe or unreliable for them to switch to the new type of DBS, use the device's remote control on their own, or attend regular clinic visits — for example, due to active or unstable cognitive or mental health conditions.
- People whose DBS electrodes have high resistance, are faulty, or produce insufficient brain signal quality, or where stimulation is mainly delivered through the outermost contact points on both sides in a way that would prevent the new DBS approach from working properly (confirm with trial site).
- People who have previously objected to their medical records being used for medical research purposes.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Maria Fiorella Contarino, MD, PhD, HagaZiekenhuis
Phone: +31 (0)70 210 2997
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Patient preference of DBS settings
Can't join this trial?
Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.